Flavan-3-ols and methylxanthines have potential beneficial effects on human health including reducing cardiovascular risk. We performed a randomized controlled cross-over intervention trial to assess the acute effects of consumption of flavan-3-ol-enriched dark chocolate, compared with standard dark chocolate and white chocolate, on the human metabolome. We assessed the metabolome in urine and blood plasma samples collected before and at 2 h and 6 h after consumption of chocolates in 42 healthy volunteers using a non-targeted metabolomics approach. Plasma samples were assessed and showed differentiation between time points with no further separation among the three chocolate treatments. Multivariate statistics applied to urine samples could readily separate the postprandial time points and distinguish between the treatments. Most of the markers responsible for the multivariate discrimination between the chocolates were of dietary origin. Interestingly, small but significant level changes were also observed for a subset of endogenous metabolites.
INTRODUCTION
Dark chocolate contains at least two groups of bioactive substances, flavan-3-ols and methylxanthines. Well known flavan-3-ols include catechin, epicatechin gallate, epigallocatechin, epigallocatechin gallate, proanthocyanidins, theaflavins, thearubigins and they are regarded as functional food ingredients 1 . The most well-known methylxanthines are theobromine, caffeine and theophylline. Dark chocolate is enriched in theobromine, with lesser amounts of caffeine and practically no theophylline 2 .
3 Flavan-3-ols have various organoleptic properties such as astringency, bitterness, sourness, and sweetness. They also have several beneficial health effects by acting as antioxidant, anticarcinogen, antimicrobial, anti-viral, and neuro-protective agents. They are also known to affect several measures of cardiovascular health, including blood pressure, vascular function 3 , platelet function 4, 5 , plasma lipids and lipid peroxidation in humans.
The bioactive effects of methylxanthines are mainly mediated by the so-called adenosine receptor blockers 6 . They may improve lung function 2 . Methylxanthines increase the thermogenic capacity of adipose tissue 7 . There is also a synergistic interaction between caffeine and catechins in increasing thermogenesis on brown adipose tissue 8 .
Very few studies have identified the fate of cocoa components in humans or rodents 9, 10 and such information may help to identify the bioactive compounds. Recently non-targeted approaches in plasma and urine were employed to assess the changes in the host and microbial metabolome after cocoa consumption in human subjects 11, 12 . Martin et al. 12 used
Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) approaches to examine human fasted plasma and urine samples to assess the chronic effects of regular consumption of dark chocolate. This study focused on endogenous metabolites involved in energy homeostasis and stress responses but lacked a control group. Llorach et al. 11 on the other hand, used a non-targeted Liquid Chromatography (LC)/MS method to identify metabolites up to 24 h after ingestion of a cocoa drink in 10 subjects but the focus was on the metabolites found in the cocoa product, the excretion of the polyphenols ingested and their products.
Previously, we performed a randomized controlled human trial (clinicaltrials.gov; NCT01099150) to evaluate the effect of flavan-3-ol-enriched dark chocolate, standard dark chocolate and white chocolate on platelet function in healthy subjects 13 . Both flavan-3-olenriched dark chocolate and white chocolate, improved several measures of postprandial 4 platelet function in a gender-specific way although the specific bioactive compounds could not be determined.
In the current analysis, we employed samples from the same study to assess the effects of acute consumption of flavan-3-ol-enriched dark chocolate, in comparison with standard dark chocolate and white chocolate, on both plasma and urinary proton NMR ( 1 H NMR) profiles and urinary MS profiles in 42 healthy humans having fasted ≥ 10 h overnight. Postprandial assessment of the human metabolome by such complementary techniques provides further insights into both the metabolism of flavan-3-ols and methylxanthines in the human body and the effects these plant bioactives have on endogenous metabolism.
MATERIAL AND METHODS

Subjects and study design
Recruitment of subjects (n = 42) and details of the crossover study design were reported previously 13 .The study was carried out in accordance with the ethical principles of the Declaration of Helsinki and Good Clinical Practice. The study was approved by the Ethics Committee of the Rowett Institute of Nutrition and Health, University of Aberdeen (reference number 09-002) following review by the North of Scotland Research Ethics Committee. This trial was registered at clinicaltrials.gov as NCT01099150. Volunteers were informed about the purpose and the risks of the study, and written informed consent was obtained from all subjects before participation.
The details are summarised in the Supporting Information Material and Methods, Figure S1 and Tables S1 and 2 .
Sampling and storage of biofluid samples was previously described 13 , as was measurement of creatinine in urine. Relevant details are supplied in the Supporting Information.
Extraction and analysis of flavonoid content of the chocolate bars
First, lipids were removed from chocolate samples as described by Cooper et al. 14 . This included the extraction of defatted and dried chocolate powder using 70% aqueous methanol containing 0.1 mg/mL galangin (282200, Sigma-Aldrich) as internal standard.
Samples were heated to 70 °C for 20 min. Supernatants were filtered and filtrates from each sample were analyzed by normal-phase HPLC as described previously. Samples were analyzed in duplicate and the resulting flavonoid contents of the chocolate bars are shown in (Table S3) .
NMR procedure
Urine samples were thawed at room temperature and prepared for 1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   6 Metabolites were identified using information found in the literature [15] [16] [17] , on the web (Human Metabolome Database, http://www.hmdb.ca/), using Chenomx software, and by use of the 2D-NMR methods COSY, HSQC, and HMBC.
Plasma (200 µL) was mixed with 400 µL saline solution (0.9% w/v NaCl in 90%/10% H 2 O/D 2 O) and 500 µL were transferred to an NMR tube. Proton NMR spectra were measured at 300 K using the same NMR equipment. Spectra were acquired using the Bruker cpmgpr1d water suppression pulse sequence, with 32 k data points, spectral width 20.8 ppm, acquisition time 1.36 s, relaxation delay 2 s, 90º pulses (11 µs), spin-echo delay 0.4 ms, loop number 300 (giving a total echo time = 240 ms) and 128 transients per spectrum. Free induction decays were zero filled and exponential line broadening of 1 Hz was applied prior to Fourier transformation. Proton NMR spectra were referenced to the anomeric α-glucose signal (δ 5.234 ppm).
NMR data analysis
NMR Spectra were prepared for statistical analysis using the Bruker AMIX software v3.9.
The spectra were divided along the horizontal axis into variable width "buckets" (or bins) using the AMIX graphical editor to draw buckets that include, where possible, recognizably complete individual peaks or multiplets. The intensities within each bucket were summed, divided by the bucket width and the bucket intensities were normalized to the same total intensity for each sample to give the final bucket table. Regions with only background noise, the urea peak and the water resonance were not included in the buckets. This gave matrices of 368 samples x 380 buckets for the urine NMR spectra and 363 samples by 101 buckets for the plasma spectra.
HPLC-TOF MS analysis
A subset of 240 urine samples (0 and 6-h post chocolate) was defrosted and vortex mixed before sampling. A portion of urine (1 mL) was centrifuged for 5 min at 9600 g and 150 µL comprehensive set of univariate analyses was also carried out on all buckets for the urine NMR data using an in-house Matlab routine. The comparison of metabolic responses to the three different chocolate types was performed on bucketed NMR spectra that were area normalised followed by two stages of probabilistic scaling 21 . First, the three baseline (time t = 0) spectra for an individual were scaled to their mean. Second, spectra collected at times t = 2 h and t = 6 h were scaled to their corresponding adjusted baseline. Post-ingestion difference spectra were calculated by subtraction of their corresponding adjusted baselines.
For both post-ingestion time points the differences in the spectral response of each bucket were ranked by their Mack-Skillings statistic 22, 23 . The top 162 & 223 buckets were found to be significantly different at 2 h and 6 h respectively, based on a FDR of q = 0.05 [22] , using p-values based on 10 7 within-block permutations 22, 23 . The significance of the differences in response at each bucket was also estimated from within-block permutations (Table S5) .
RESULTS
We recruited 42 healthy subjects, each receiving three acute treatments (flavan-3-olenriched dark chocolate (EDC), standard dark chocolate low in flavan-3-ols (DC), or white were separated by two washout periods of at least two weeks. This crossover design provided optimal statistical power as each subject acted as their own control.
Dietary markers mainly contribute to the discrimination of the metabolite profiles
Plasma NMR spectra were assessed by PLSDA and showed differentiation between 0h and later time points but no discrimination between the three chocolate treatments ( Figure S2 ).
Differentiation was caused by elevation of lactate at 2h and aspartate, acetoacetate, acetone and β-hydroxybutyrate levels at 6 h after ingestion 24 .
A series of Principal Component Analysis (PCA) models were created from urine 1 H NMR and LC/MS data to assess whether there was separation between dietary treatments at 0 h, The discrimination of samples from the EDC group and to some extent the DC group versus the baseline group (0h) and WC group (seen on PC4 in Figure 1a and PC2 in Figure 2b) was largely due to an increase in the intensity of buckets containing signals from epicatechin derivatives, theobromine and its methylxanthine derivatives ( Figure S3 d-e) in the EDC and DC groups. 
Assignment of the dietary markers and their levels across the three chocolate treatments
Epicatechin derivatives and methylxanthines were detected in urine samples by both 1 H NMR and LC/TOF-MS. Comparison of HSQC and COSY spectra of 6h EDC and WC urines (same volunteer) revealed many new peaks in the EDC spectra that were not present in the WC. The signals were assigned as theobromine or epicatechin metabolites using information from the HMDB, literature, or via spiking (theobromine itself). Several buckets between 3.5 and 4.0 ppm containing signals arising from 3-and 7-methylxanthines and theobromine (3,7- dimethylxanthine) as well as the singlets from the corresponding xanthine purine rings at 8.03, 7.86 and 7.91 ppm were all strong markers in the urines from volunteers having ingested either DC or EDC ( Figure 2 and Table 1 ).
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Concentration of flavanol-3-ols and methylxanthines in chocolate.
The combined caffeine and theobromine concentrations were quite similar in both dark chocolates. The flavanol-3-ol enriched chocolate had a combined content of 1.12% whilst the standard dark chocolate contained 1.23%. (Table S1 ). The enriched dark chocolate contained 1.5% total flavonoids compared to 0.64% in the standard dark chocolate (Table   S3 ). Neither methylxanthines nor flavonoids were detected in the white chocolate.
Changes in endogenous metabolite levels across the three chocolate treatments
The urinary 1 H NMR spectra recorded were segmented into 380 buckets and univariate analyses were carried out on the bucket intensities. Of these buckets, 223 had a p-value lower than 0.05 when the three chocolate treatments were compared at 6 h (see Table S5 ).
The markers with the lowest p values were assigned to catechin and xanthine derivatives.
Interestingly, a subset of endogenous metabolites was affected by the chocolate intake, mainly by the two dark chocolates (Table 3) . Urinary levels of several amino acids (Ala, Val, Gly) and organic acids (2-and 3-hydroxyisobutyrate, 3-hydroxyisovalerate) were significantly decreased 6 h after intake of both dark chocolates compared with white chocolate and all followed the same trend: mean level in flavan-3-ol-enriched dark chocolate < dark chocolate < white chocolate. Additionally, a few energy compounds also followed the same trend, namely creatinine, N 1 -methylnicotinamide (NMA) and lactate. Interestingly pyruvate followed an inverse trend where levels were increased by flavan-3-ol-enriched dark chocolate and dark chocolate compared with white chocolate. Levels of tyrosine and its microbial product (para-hydroxyphenylacetate) were also elevated after consumption of both dark chocolates (Table 3) . Trends for selected markers can be found in Figure 4 . 
Changes in metabolite levels associated with gender and age
Differences in levels of the main xanthine metabolites (3-and 7-methylxanthine and theobromine) and the buckets at 6.11, 6.13 and 6.15 ppm reflecting catechin derivatives were investigated further by subdividing the treatment groups according to gender, BMI and age, at 2-and 6-h post chocolate. Only theobromine excretion levels showed a significant difference with respect to gender, with higher levels being excreted by females compared with males. The gender differences were being observed for both dark chocolates at the 6 h and for standard dark chocolate at the 2 h time point. There was also an effect of the age on the levels of the same metabolite with a higher excretion for volunteers aged 29 or younger compared with volunteers older than 54 ( Figure 5 ). Figure 5 .
DISCUSSION
In this study we assessed acute effects of consumption of flavan-3-ol-enriched dark chocolate in comparison with a standard dark and a white chocolate on plasma and urinary 1 H NMR profiles and urinary MS profiles in healthy humans. Both urinary and plasma profiles showed wide-scale metabolite composition changes post-chocolate intake. Multivariate and univariate analyses coupled to metabolite identification revealed that the major differences between treatments were found in urine and changes were related to both intake markers as well as markers of endogenous metabolism.
There was no differentiation between the three treatment groups in the plasma 1 H NMR profiles contrary to the many changes detected in the urinary profiles. No theobromine or catechin derived metabolites were found because plasma concentrations of these were under the detection limit for NMR.
Changes detected in the urinary profiles principally affected a number of NMR buckets between 3.00 and 4.00 ppm, and in the regions of 6.10 and 8.00 ppm after both dark chocolate treatments. Those signals were attributed to metabolized compounds of dietary origin (catechin 25 and methylxanthine 26 derivatives). Interestingly Martin et al 12 detected an increase in levels of two unknown singlets at 7.85 and 7.91 ppm after one week of chronic intake of dark chocolate which were most likely peaks arising from 7-methylxanthine and Page 16 of 31 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 theobromine (see Table 1 ). The levels of an unknown at 3.39 ppm detected in the present study were also increased in their study. Caffeine itself was not detected in the urinary spectra because the levels were too low to be detected. For comparison the abundance of theobromine in the dark chocolates was six times that of caffeine (supplementary Table 3) yet only theobromine and two main products (3 and 7-methyl xanthines) were detected by 1 However, there was no increase in hippurate levels in our study although this metabolite of microbial origin has been recognized as the main excretion product from polyphenols such as catechins and from green and black tea consumption 28, 29 .
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There was an increase of para-hydroxyphenylacetate (HPA) 6 h after ingestion of both dark chocolates. Hydroxyphenylacetate is related to food intake and breakdown processes by gut microbiota 30 . It originates from dietary phenolic compounds, including the catechins contained in dark chocolate. The increase of HPA was accompanied with an increase of tyrosine, an abundant component of cacao seeds 11 .
We did not observe changes in levels of citric acid cycle compounds such as succinate or citrate but, as in a study on consumption of black tea polyphenols 31 , we saw an increase of pyruvate in urine. Additionally, we saw a reduction in lactate at 6 h post-intake of flavan-3-olenriched dark chocolate. The lactate levels increased at 6h for WC compared to 0h and to EDC or DC at 6h. Whilst we cannot elucidate the mechanisms of such changes based on metabolomics results alone, it is possible that, glycolysis and/or gluconeogenesis might be Page 17 of 31 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 enhanced by the catechin-rich chocolate thus increasing levels of excreted pyruvate 32, 33 .
Concomitantly, a large intake of catechins might have affected anaerobic respiration, leading to a reduced production of lactate. Furthermore, the urinary levels of four glucogenic amino acids, arginine, valine, alanine and glycine, were reduced after consumption of flavan-3-olenriched dark chocolate, suggesting a possible redirection of the energy metabolism towards gluconeogenesis 33 following catechin intake ( Table 3 ).
The urinary levels of both creatinine and N 1 -methylnicotinamide (NMA) were reduced following intake of both dark chocolates but creatinine was increased by WC at 6h. The levels of creatinine and NMA in WC were higher than EDC or DC at 6h as shown in Figure 4 .
Creatinine is a clearance product from phosphocreatine (PCr) which itself is a phosphate donor for sudden adenosine triphosphate (ATP) demand and NMA arises from dietary niacin and from tryptophan metabolism 34 . Wang et al 35 proposed a link between creatinine urinary levels, oxidative stress and modulation of oxidative stress by antioxidants which could be attributed to catechins in both dark chocolates. A decrease in creatinine may be associated with a better regulation of the PCr pool and ATP usage. Note that a decrease in creatinine has already been observed by Martin et al 12 .
This similarity indicates that both acute and chronic intake of dark chocolate may affect the energy metabolism in a similar way.
A decrease in NMA would indicate an upregulation towards the production of NAD + and energy expenditure 36 . Also NMA is an activator of prostacyclin (PGI 2 ) production which may regulate thrombotic as well as inflammatory processes in the endothelial vascular system via anti-platelet effects 37, 38 . In our case, decreases in creatinine and NMA urinary levels may indicate effects on metabolic regulation bringing potential health benefits through the action of chocolate bioactive ingredients.
Martin et al 12 showed that dark chocolate had an effect on the energy metabolism and on metabolites from gut microbiota. Products from the gut microbiota are commonly found in biological fluids including urine, plasma or faecal waters 39 . These include methylamine, We observed a urinary decrease of DMA in urine 6 h after ingestion of both dark chocolates.
Dimethylamine is a product of TMA and TMAO. It is difficult to assess if a reduction of DMA is beneficial to health. Wang et al 40 reported that supplementation of mice with choline, TMAO or betaine promoted upregulation of multiple macrophage scavenger receptors linked to atherosclerosis, and supplementation with choline or TMAO promoted atherosclerosis.
Therefore, it appears that lower endogenous levels of methylamines may be beneficial to health.
The short chain hydroxy acids, 3-hydroxyisovalerate, 2-hydroxyisobutyrate and 3-hydroxyisobutyrate, were reduced following intake of both dark chocolates but increased from 0h to 6h after WC. These acids are normally found at low levels in urine of healthy individuals 41 and at high levels in urine and blood of patients suffering from branched-chain organic acidurias 42 or other acidosis 43 . Both 3-hydroxyisovalerate and 3-hydroxyisobutyrate are intermediates in the catabolism of branched amino acids such as leucine and valine and 2-hydroxyisobutyrate has been reported as being a gut metabolite increased in the urine of healthy humans eating a diet high in proteins 41 . Newgard et al 44 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   20 recovery of < 2%) and are known to be metabolized by cytochrome P450 (CYP450) enzymes during phase II excretion 27, 45 .
In this study, females excreted on average almost twice as much theobromine as males 6 h after intake of both dark chocolates and there was also a significant dependence of theobromine excretion on age with flavan-3-ol-enriched dark chocolate treatment. Some previous studies reported no gender effect on elimination following an intake of caffeine, theobromine or theophylline 27, 46, 47 while others reported the inverse 45 . Additionally, Agarwal 48 showed that in vitro arginine 8 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21
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